glp 1 hyper responder Outpatient Sedation Basics for Patients on GLP-1 Medications Glucagon-like peptide-1 receptor: mechanisms and

The distribution of protein intake across the day is as important as total daily amount for optimizing muscle protein synthesis and preservation during GLP-1 therapy

3.1.4 Exenatide and its combination with MET: from metabolic improvement to pregnancy outcomes The evidence chain for exenatide is relatively long, encompassing early RCTs focused on menstruation, ovulation, and metabolism, as well as follow-up studies targeting pregnancy outcomes

Since inhibition of FXR in intestinal L cells is able to promote GLP-1 release 11 , changes in BA composition or profiles are likely to affect glucose homeostasis by controlling insulin secretion via modulating GLP-1 production

doi:10.3389/fendo.2020.00191 63

Only 4-7% of participants in SURMOUNT-1 and 2 discontinued the medication due to AE (Tables 2, 3)